He has managed significant service developments including networked radiotherapy and chemotherapy centres across Greater Manchester, transforming delivery of Christie services to an outpatient model. He directed the establishment of Christie partnerships for pathology, specialist diagnostic services and private patients, academic investment plan and the establishment of the first national proton therapy service in the UK.

In 2016 he led the Trust to a CQC Outstanding rating, repeated again in 2018. 

Roger led for Greater Manchester the National Cancer Vanguard developing and testing new models of care and was a member of the long term plan working group. He is the executive lead for Greater Manchester Cancer Alliance. 

In December 2018 Roger was appointed to the Healthcare UK Advisory Board. The Advisory Board is accountable to the Department for International Trade (DIT) and Department of Health & Social Care (DHSC) ministers.  

Roger holds an MBA, an honours degree in Nursing Studies and is a Registered Nurse.